Novel, Single-Dose Microsphere Formulation of Azithromycin Versus 7-Day Levofloxacin Therapy for Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.49.10.4035-4041.2005
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2005
Authors
Publisher
American Society for Microbiology